What is Epigenetics by Prof. André SCHEEN
Epigenetics is one of the most promising research areas regarding the development of certain diseases, particularly type 2 diabetes The Professor André SCHEEN, President of…
« Promote and support research on diabetes
and metabolic diseases. »
For the advancement of diabetes research
TRANSFORM YOUR LEGACT INTO LASTING IMPACT…
If you want to play a crucial role in the fight against diabetes and contribute to future advancements…
If you wish to enhance the lives of diabetic patients through a powerful act of generosity…
Consider making a bequest and pass on the hope that diabetes will be eradicated one day…
Epigenetics is one of the most promising research areas regarding the development of certain diseases, particularly type 2 diabetes The Professor André SCHEEN, President of…
Deadline for receiving opinions and comments from experts for submission to the Scientific Council
Find FFRD at the Associations Village
Shared booth with our partner SFD
Diabetes mellitus affects 5% of the French population and is a major burden for the persons living with this chronic disease, with potentially serious complications and high costs induced. Major and continuous improvements have been made for a botter understanding of the mechanisms of the disease and its complications, and for its monitoring and treatment as well.
The FFRD supports clinical, basic, and translational research.
The supported basic research projects address major themes of type 1 and type 2 diabetes
covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.
The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes
and often involve large multicenter cohort studies.
Since 2013, the Foundation has been: